Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SHZ: 002864.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dezhu Zhang
- Employees
- 864
- Headquarters
- Xi'an, China
- IPO year
- 2017
- Market cap
- CN¥3.3B
- Website
- https://www.pljt.com
Loading 002864…
Loading profile data…Frequently asked questions about 002864
What does Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) do?
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells drugs and GAP cultivation of medicinal materials in China. It offers orthopedic, cardio-cerebrovascular, digestive, supplement category, respiratory, Chinese anti-inflammatory, pediatric, gynecology, hepatobiliary, and specialty drugs. The comp...
Where does 002864.SZ trade?
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002864.SZ in?
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd?
Dezhu Zhang is the chief executive officer of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ).
Where is Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd headquartered?
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is headquartered in China.
Does 002864.SZ pay a dividend?
Yes — Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) paid a trailing twelve-month dividend of CNY 0.35 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002864.SZ go public?
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) completed its initial public offering in 2017.